elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38110142-E27F4DF9-1B4A-4BA6-B542-52FEC23F6AB5
Q38110142-E27F4DF9-1B4A-4BA6-B542-52FEC23F6AB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38110142-E27F4DF9-1B4A-4BA6-B542-52FEC23F6AB5
Using higher doses to compensate for tubing residuals in extended-infusion piperacillin-tazobactam.
P2860
Q38110142-E27F4DF9-1B4A-4BA6-B542-52FEC23F6AB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38110142-E27F4DF9-1B4A-4BA6-B542-52FEC23F6AB5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2cb30fd34ffe868c96d01ddba6d3740f4d04df27
P2860
Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital.